Single-use bioprocessing system refers to biopharmaceutical manufacturing equipment designed to be used once (or for a single manufacturing campaign) and then discarded. Generally, SUS equipment is composed primarily of plastic components that have been sealed and sterilized using gamma irradiation. The primary benefits of SUS versus classic stainless steel (or glass less frequently used in bioprocessing) is that the equipment comes sterile, allowing avoidance of cleaning, sterilization, and validation of sterilization prior to usage; and avoidance of related complex steam, WFI, and other plumbing installed throughout bioprocessing facilities with large fixed stainless steel components. With SUS equipment essentially plug-and-play, process turnaround and set up of new processing lines are much quicker, avoiding weeks of cleaning/sterilization/validation required with reused stainless steel equipment.
In addition, with much less facility infrastructure required, including no need for a lot of plumbing or an in-house WFI plant, and with bioprocessing suites as simple as empty rooms to be filled with a SUS-assembled process line, the facility footprint can be much smaller, investment & construction costs much lower, and new process lines & facilities come online much faster & simpler versus stainless steel.
The key factors that drive the demand for single-use bioprocessing products include rise in adoption of single use technologies across pharmaceutical manufacturing facilities, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. This has further led to the development of single-use bioprocessing products using advanced materials as shelf-life of SUB products relies upon the stability of plastic ware and its sterility.
The Single-Use Bioprocessing Material market in this report is studied on the basis of material, application, and region. On the basis of material, the market is divided into plastic, silicone, and others. By plastic materials, the market is further divided into polyethylene, polyvinyl chloride, polyamide, polyvinylidene fluoride, and other plastic materials. By application, the market is classified into media bags & containers, tubes, filters, sampling systems, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America dominated the market in 2020, owing to increased demand for biopharmaceuticals owing to the rise in geriatric population. The advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the North America single-use bioprocessing material market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to presence of favorable government support, rise in private investments, growth in geriatric population, surge in trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries.
The major players operating in the global Single-use bioprocessing material market are Arkema S.A., BASF SE, Celanese Corporation, Dow Inc., Evonik Industries AG, Exxon Mobil Corporation, LyondellBasell Industries N.V., Mitsubishi Chemical Holdings Corporation, Saudi Basic Industries Corporation (SABIC), and Compagnie de Saint-Gobain S.A. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
In addition, with much less facility infrastructure required, including no need for a lot of plumbing or an in-house WFI plant, and with bioprocessing suites as simple as empty rooms to be filled with a SUS-assembled process line, the facility footprint can be much smaller, investment & construction costs much lower, and new process lines & facilities come online much faster & simpler versus stainless steel.
The key factors that drive the demand for single-use bioprocessing products include rise in adoption of single use technologies across pharmaceutical manufacturing facilities, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. This has further led to the development of single-use bioprocessing products using advanced materials as shelf-life of SUB products relies upon the stability of plastic ware and its sterility.
The Single-Use Bioprocessing Material market in this report is studied on the basis of material, application, and region. On the basis of material, the market is divided into plastic, silicone, and others. By plastic materials, the market is further divided into polyethylene, polyvinyl chloride, polyamide, polyvinylidene fluoride, and other plastic materials. By application, the market is classified into media bags & containers, tubes, filters, sampling systems, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Region wise, North America dominated the market in 2020, owing to increased demand for biopharmaceuticals owing to the rise in geriatric population. The advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the North America single-use bioprocessing material market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to presence of favorable government support, rise in private investments, growth in geriatric population, surge in trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries.
The major players operating in the global Single-use bioprocessing material market are Arkema S.A., BASF SE, Celanese Corporation, Dow Inc., Evonik Industries AG, Exxon Mobil Corporation, LyondellBasell Industries N.V., Mitsubishi Chemical Holdings Corporation, Saudi Basic Industries Corporation (SABIC), and Compagnie de Saint-Gobain S.A. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the single-use bioprocessing material market size analysis from 2020 to 2030 to identify the prevailing single-use bioprocessing material market opportunities.
- The single-use bioprocessing material industry research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the single-use bioprocessing material market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global single-use bioprocessing material market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Material
- Plastic
- Silicone
- Others
By Application
- Media Bags Containers
- Tubes
- Filters
- Sampling Systems
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Turkey
- South Africa
- Rest of LAMEA
Key Market Players
- Arkema, Inc.
- Dow chemical company
- saint gobain
- Exxon Mobil Corporation
- Mitsubishi Chemical Advanced Materials
- LyondellBasell Industries Holdings B.V.
- SABIC
- BASF
- Celanese Corporation
- evonik industries ag
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY MATERIAL
CHAPTER 5: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY APPLICATION
CHAPTER 6: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
The single-use bioprocessing materials include a variety of systems, which are used for both upstream and downstream processing. The systems used in the upstream processing mainly include bioreactors, bioprocess containers, disposable mixers, media bags, membrane absorbers, and samplers. The systems used in the downstream processing mainly consist of connectors, depth fillers, disposable filter cartridges, tangential flow filters, and tubing. Single-use technologies are disposable products that are intended for one-time use. Typically, these disposable products are made of various types of plastic that can be in any of the following forms:Polyamide - a synthetic material like nylon
Polycarbonate - thermoplastic polymers created with carbonate groups
Polyethylene - a common type of plastic used in clear films and bags
Polyethersulfone - heat-resistant plastic
Polypropylene - complex thermoplastic used in both disposable and reusable applications
Polytetrafluorethylene - synthetic compound of fluoropolymer of tetrafluoroethylene with many uses
Polyvinyl chloride - typically white, a plastic compound that is resistant to heat and moisture; commonly referred to as PVC
Cellulose acetate - hard plastic that is made from the acetate ester of cellulose
Ethylene vinyl acetate - EVA is the copolymer of vinyl acetate and ethylene
Owing to the specialized approaches needed to address specific and unique characteristics in bioproduction, SUTs provide solutions that address these needs in the development and manufacturing of biopharmaceuticals.
Single-use bioprocessing technology has gained significant traction in the recent years, owing to rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. This has fueled the manufacturers to integrate different materials in the construction of single-use bioprocessing products. These products have also proved beneficial for the small scale pharmaceutical manufacturers. Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components on commercial scale. This has spurred the demand for high-grade plastic and silicone materials in the development of SUB products.
The single-use bioprocessing material industry is expected to witness significant growth during the forecast period due to factors such as increase in prevalence of diabetes, growth in geriatric population, rise in incidence of blindness owing to diabetes, and augment in focus on awareness, which facilitate early diagnosis to control the disease. Although these factors garner the growth of the market, dearth of skilled ophthalmologists and extended approval time for drugs can pose as a major obstacle for the growth of the single-use bioprocessing materials market size. On the other hand, emergence of combined therapies for treatment of diabetic macular edema and the emerging markets of Asia-Pacific & LAMEA are anticipated to provide several opportunities for the single-use bioprocessing material market share.
The single-use bioprocessing material market size in this report is studied on the basis of material, application, and region. On the basis of material, the market is divided into plastic, silicone, and others. On the basis of material, the plastic single-use bioprocessing material segment currently dominates the global single-use bioprocessing material market and this single-use bioprocessing material market trends is expected to continue during the forecast period owing to features of plastics such as low cost, ease of manufacture, versatility, and resistant to damage caused by water. The adoption toward use of plastic materials in single-use bioprocessing has gained traction considerably, in spite of the emerging biopharmaceutical production concerns pertaining to these materials.
By application, the market is classified into media bags & containers, tubes, filters, sampling systems, and others. On the basis of application, the media bags and containers segment dominated the global single-use bioprocessing material market in 2020 and is anticipated to be dominant in the market as they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.
North America dominated the market in 2020, owing to increased demand for biopharmaceuticals owing to the rise in geriatric population. The advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drive the adoption of the North America single-use bioprocessing material market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to presence of favorable government support, rise in private investments, growth in geriatric population, surge in trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries.
According to Onkar Sumant, Manager, Healthcare, 'The demand for single-use bioprocessing technology has witnessed an increase over the years owing to the rise in demand for continuous bio-production in the biopharmaceutical industries. Various market players constantly strive to develop innovative treatment solutions; hence, focus on adopting novel single-use bioprocessing technologies. The continuous demand for single use systems boost the single-use bioprocessing material market growth. In addition, it ensures proper compliance of product contact materials to avoid any further potential roadblock during the product launch in the market.'
KEY FINDINGS OF STUDY
On the basis of material, the plastic single-use bioprocessing material segment currently dominates the global single-use bioprocessing material market and is expected to continue during the forecast period owing to features of plastics such as low cost, ease of manufacture, versatility, and resistant to damage caused by water. The adoption toward use of plastic materials in single-use bioprocessing has gained traction considerably, in spite of the emerging biopharmaceutical production concerns pertaining to these materials.
On the basis of application, the media bags and containers segment dominated the global single-use bioprocessing material market in 2020 and is anticipated to be dominant in the market as they provide a single-use disposable alternative to traditional glass and rigid plastic carboys in a large variety of bioprocess applications. They enhance process reliability as they reduce the risk of cross-contamination from batch to batch and from product to product. They also eliminate the time and expense of clean-in-place (CIP) & sterilization-in-place (SIP) operations, thus optimizing capacity utilization. The expanded application of single-use bags across biomanufacturing processes drives the market for single-use media bags.
Region wise, North America dominated the market in 2020, owing to increased demand for biopharmaceuticals owing to the rise in geriatric population. The advantages of single-use bioprocessing (such as high energy efficiency, low water usage, less floor space requirement, reduced installation cost, decreased risk of product cross-contamination, and fast implementation) drives the adoption of the North America single-use bioprocessing material market. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to presence of favorable government support, rise in private investments, surge in geriatric population, rising trend of outsourcing to emerging Asian markets, and presence of a skilled workforce in these countries.
Companies Mentioned
- Arkema, Inc.
- Dow chemical company
- saint gobain
- Exxon Mobil Corporation
- Mitsubishi Chemical Advanced Materials
- LyondellBasell Industries Holdings B.V.
- SABIC
- BASF
- Celanese Corporation
- evonik industries ag
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
